The nature and structure of psychological distress in people at high risk for melanoma: A factor analytic study

Psycho-Oncology

Volumn 21, Issue 8, 2012, Pages 845-856

  Kasparian, Nadine A ^a,b,c   Sansom Daly, Ursula ^c   McDonald, Roderick P ^a   Meiser, Bettina ^b,d   Butow, Phyllis N ^a   Mann, Graham J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

anxiety; cancer; depression; factor analysis; melanoma; oncology; psychological distress

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ANXIETY DISORDER; ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPACT OF EVENTS SCALE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PSYCHOMETRY; QUESTIONNAIRE; ADOLESCENT; ANXIETY; FACTORIAL ANALYSIS; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGY; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84864464985     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1976     Document Type: Article

References (88)

1. Kasparian N, McLoone J, Butow P,. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145: 1415-1427.
2. American Psychiatric Association. Diagnostic and Stastical Manual of Mental Disorders (4th edn), American Psychiatric Association. Washington DC, 1995.
3. Kelly B, Raphael B, Smithers M, et al,. Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry 1995; 17 (2): 126-134.
4. Lindberg N, Wellisch D,. Identification of traumatic stress reactions in women at increased risk for breast cancer. Psychosomatics 2004; 45 (1): 7-16. (Pubitemid 38082503)
5. Smith MY, Redd WH, Peyser C, Vogl D,. Post-traumatic stress disorder in cancer: a review. Psycho-Oncology 1999; 8 (6): 521-537. (Pubitemid 30014685)
6. Horowitz M, Wilner N, Alvarez W,. Impact of Events Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218. (Pubitemid 9219271)
7. Joseph S,. Psychometric evaluation of Horowitz's Impact of Event Scale: a review. J Trauma Stress 2000; 13 (1): 101-113. (Pubitemid 30171853)
8. Kasparian N, Meiser B, Butow P, Simpson J, Mann G,. Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med 2009; 11 (4): 265-278.
9. Kasparian N, Meiser B, Butow P, Simpson J, Mann G,. Predictors of psychological distress among individuals with a strong family history of malignant melanoma. Clin Genet 2008; 73: 121-131.
10. Riedijk S, de Snoo F, van Dijk S, et al,. Hereditary melanoma and predictive genetic testing: why not? Psycho-Oncology 2005; 14: 738-745. (Pubitemid 41320787)
11. Bishop DT, Demenais F, Goldstein AM, et al,. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Nat Cancer Inst 2002; 94 (12): 894-903. (Pubitemid 34778088)
12. Kash KM, Holland JC, Halper MS, Miller DG,. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992; 84 (1): 24-30.
13. Kent G, Howie H, Fletcher M, Newbury-Ecob R, Hosie K,. The relationship between perceived risk, thought intrusiveness and emotional well-being in women receiving counselling for breast cancer risk in a family history clinic. Br J Health Psychol 2000; 5: 15-26. (Pubitemid 30088782)
14. Thirlaway K, Fallowfield L, Nunnerley H, Powles T,. Anxiety in women 'at risk' of developing breast cancer. Br J Cancer 1996; 73 (11): 1422-1424. (Pubitemid 26175678)
15. Hailey BJ, Carter CL, Burnett DR,. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care Women Int 2000; 21 (8): 701-715.
16. Lerman C, Kash K, Stefanek M,. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Nat Cancer Inst Monogr 1994;(16): 171-176.
17. Valdimarsdottir H, Bovbjerg DH, Kash K, Holland J, Osborne M, Miller D,. Psychological distress in women with a familial risk of breast cancer. Psycho-Oncology 1995; 4: 133-141. (Pubitemid 26093045)
18. Lloyd S, Watson M, Waites B, et al,. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996; 74 (3): 482-487. (Pubitemid 26254584)
19. Watson M, Lloyd S, Davidson J, et al,. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999; 79 (5-6): 868-874. (Pubitemid 29082119)
20. Lerman C, Daly M, Sands C, et al,. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993; 85 (13): 1074-1080. (Pubitemid 23199189)
21. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, et al,. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 1997; 19 (4): 362-369. (Pubitemid 28363405)
22. Thewes B, Meiser B, Hickie I,. Psychometric properties of the Impact of Events Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 2001; 10 (6): 459-468. (Pubitemid 33081032)
23. Lerman C, Schwartz M, Miller S, Daly M, Sands C, Rimer B,. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol 1996; 15 (2): 75-83. (Pubitemid 126468479)
24. Lerman C, Schwartz M, Narod S, Hsiang Lin T, Hughes C, Lynch H,. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997; 65 (3): 414-420. (Pubitemid 27246782)
25. Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K, Group NCfRiFBCP. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. J Womens Health 2003; 12 (8): 769-778. (Pubitemid 37361919)
26. Croyle R, Smith K, Botkin J, Baty B, Nash J,. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997; 16 (1): 63-72. (Pubitemid 127465954)
27. Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A,. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology 1998; 7: 402-412. (Pubitemid 28494052)
28. Streiner D, Norman G,. Health Measurement Scales. Oxford University Press: Oxford, 1995.
29. Kangas M, Henry JL, Bryant RA,. Posttraumatic stress disorder following cancer. a conceptual and empirical review. Clin Psychol Rev 2002; 22 (4): 499-524. (Pubitemid 34462891)
30. Jim HS, Jacobsen PB,. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J 2008; 14 (6): 414-419.
31. Horowitz M, Wilner N, Alvarez W,. The Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218. (Pubitemid 9219271)
32. Goldstein A, Chan M, Harland M, et al,. The Lund Melanoma Study Group, and The Melanoma Genetics Consortium (GenoMEL). Assessment of high-risk melanoma susceptibility genes and their associations with pancreatic cancer, neural system tumors, and uveal melanoma: a Melanoma Genetics Consortium (GenoMEL) study. Cancer Res 2006; 66: 9818-9828. (Pubitemid 44672032)
33. Holland E, Schmid H, Kefford R, Mann G,. CDKN2A (p16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 1999; 25: 339-348. (Pubitemid 29326140)
34. Bishop D, Demenais F, Goldstein A, et al,. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94: 894-903. (Pubitemid 34778088)
35. Cella D, Mahon SM, Donovan M,. Cancer recurrence as a traumatic event. Behav Med 1990; 16: 15-22. (Pubitemid 20166171)
36. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L,. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994; 30A (1): 37-40. (Pubitemid 24058086)
37. Bjelland I, Dahl A, Haug T, Neckelmann D,. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52 (2): 69-77. (Pubitemid 34192886)
38. McDonald RP, Fraser C,. COFA87: common factor analysis. Unpublished program available from the authors. 1987.
39. McDonald RP,. Semi-confirmatory factor analysis: the example of anxiety and depression. Structural Equation Modeling 2005; 12 (1): 163-172. (Pubitemid 40163169)
40. McDonald RP, Fraser C,. CONFA: confirmatory factor analysis. Unpublished program available from the authors. 1997
41. McDonald RP, Ho M-HR,. Principles and practice in reporting structural equation analyses. Psychol Methods 2002; 7 (1): 64-82.
42. McDonald RP, Marsh HW,. Choosing a multivariate model: noncentrality and goodness of fit. Psychol Bull 1990; 107: 247-255.
43. Browne M, Cudeck R,. Alternative ways of assessing model fit. In Testing Structural Equation Models, Bollen K, Long J, (ed.). Sage: Newbury Park, CA, 1993; 136-162.
44. Cronbach L,. Essentials of Psychological Testing (3rd edn). Harpers Row: New York, 1970.
45. Audrain J, Schwartz M, Lerman C, Hughes C, Peshkin B, Biesecker B,. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1997; 19 (4): 370-377. (Pubitemid 28363406)
46. McLoone J, Watts K, Menzies S, Meiser B, Butow P, Kasparian N,. When the risks are high: psychological experiences and unmet needs of melanoma survivors at high risk of developing new primary disease. Qual Health Res 2011; under review.
47. Zilberg N, Weiss D, Horowitz M,. Impact of Event Scale: a cross-sectional validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol 1982; 50: 407-414. (Pubitemid 13212729)
48. Erblich J, Bovbjerg D, Valdimarsdottir H,. Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 2000; 22 (1): 53-59. (Pubitemid 30603112)
49. Reichelt J, Heimdal K, Moller P, Dahl A,. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 2004; 3: 21-28. (Pubitemid 40655350)
50. Solomon Z, Mikulincer M, Arad R,. Monitoring and blunting: implications for combat-related post-traumatic stress disorder. J Trauma Stress 1991; 4: 209-221.
51. McCaul KD, Branstetter AD, O'Donnell SM, Jacobson K, Quinlan KB,. A descriptive study of breast cancer worry. J Behav Med 1998; 21 (6): 565-579. (Pubitemid 29024649)
52. Cordova M, Studts J, Hann D, Jacobsen P, Andrykowski M,. Symptom structure of PTSD following breast cancer. J Trauma Stress 2000; 13: 301-319. (Pubitemid 30333798)
53. Schwarzwald J, Solomon Z, Weisenberg M, Mikulincer M,. Validation of the Impact of Event Scale for psychological sequelae of combat. J Consult Clin Psychol 1987; 55: 251-256.
54. Joseph S, Williams R, Yule W, Walker A,. Factor analysis of the Impact of Event Scale in survivors of two disasters at sea. Pers Individ Dif 1992; 13: 693-697.
55. Hodgkinson P, Joseph S,. Fcator analysis of the Impact of Event Scale with female bank staff following a raid. Pers Individ Dif 1995; 19: 773-775.
56. Joseph S, Yule W, Williams R, Hodgkinson P,. The Herald of Free Enterprise disaster: measuring post-traumatic symptoms thirty months on. Br J Clin Psychol 1993; 32: 327-332.
57. Yule W, Ten Bruggencate S, Joseph S,. Principle component analysis of the Impact of Event Scale in children who survived a shipping disaster. Pers Individ Dif 1994; 16: 685-691.
58. Robbins I, Hunt N,. Validation of the IES as a measure of the long-term impact of war trauma. Br J Health Psychol 1996; 1: 87-90.
59. Weathers F, Keane T, King L, King D,. Psychometric theory in the development of post-traumatic stress disorder assessment tools. In Assessing Psychological Trauma and PTSD, Wilson J, Keane T, (eds.). Guilford Press: New York, 1996; 399-411.
60. Sollner W, Zschocke I, Zingg-Schir M, et al,. Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosomatics 1999; 40 (3): 239-250. (Pubitemid 29232817)
61. van Roosmalen MS, Stalmeier PF, Verhoef LC, et al,. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A 2004; 124 (4): 346-355. (Pubitemid 38141375)
62. Meiser B, Butow P, Barratt A, et al,. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 1999; 75: 122-129. (Pubitemid 29477814)
63. Kim Y, Duhamel K, Valdimarsdottir H, Bovbjerg D,. Psychological distress among healthy women with family histories of breast cancer: effects of recent life events. Psycho-Oncology 2005; 14 (7): 555-563. (Pubitemid 41025281)
64. Schwartz M, Peshkin B, Hughes C, Main D, Isaacs C, Lerman C,. Impact of BRCA1/BRCA2 mutation testing on psychological distress in a clinic-based sample. J Clin Oncol 2002; 20 (2): 514-520. (Pubitemid 34072536)
65. Green SB, Lissitz RW, Mulaik SA,. Limitations of coefficient alpha as an index of test unidimensionality. Educ Psychol Meas 1977; 37 (4): 827-838.
66. King D, Leskin G, King L, Weathers F,. Confirmatory factor analysis of the Clinician-Administered PTSD scale: evidence for the dimensionality of posttraumatic stress disorder. Psychol Assess 1998; 10: 90-96. (Pubitemid 28292793)
67. Joseph S, Williams R, Yule W,. Understanding Post-Traumatic Stress: A psychosocial perspective on PTSD and treatment. Wiley: Chichester, 1997.
68. Brewin C, Dalgleish T, Joseph S,. A dual representation theory of posttraumatic stress disorder. Psychol Rev 1996; 103: 670-686. (Pubitemid 126664718)
69. Power M, Dalgleish T., Cognition and Emotion: From Order to Disorder. Psychology Press: Hove, 1997.
70. Green BL, Rowland JH, Krupnick JL, et al,. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 1998; 39: 102-111. (Pubitemid 28196468)
71. Gotay CC, Pagano IS,. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes 2007; 5: 15.
72. Easterling DV, Leventhal H,. Contributions of concrete cognitionj to emotion: neutral symptoms as elicitors of worry about cancer. J Appl Psychol 1997; 74 (5): 787-796.
73. Hirai K, Shiozaki M, Motooka H, et al,. Discrimination between worry and anxiety among cancer patients: development of a brief cancer-related worry inventory. Psycho-Oncology 2008; 17: 1172-1179.
74. Lee-Jones C, Humphris G, Dixon R, Hatcher MB,. Fear of cancer recurrence-a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology 1997; 6 (2): 95-105. (Pubitemid 27288402)
75. Northouse LL,. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 1981; 4 (3): 213-220.
76. Mishel MH,. Reconceptualization of the uncertainty in illness theory. J Nurs Scholarship 1990; 22 (4): 256-262.
77. Mishel MH,. Uncertainty in illness. J Nurs Scholarship 1988; 20 (4): 225-232.
78. Herrmann C,. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42 (1): 17-41. (Pubitemid 27095712)
79. Lisspers J, Nygren A, Soderman E,. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997; 96: 281-286. (Pubitemid 27428240)
80. Moorey S, Greer S, Watson M, et al,. The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br J Psychiatry 1991; 158: 255-259.
81. Savard J, Laberge B, Gauthier J, Ivers H, Bergeron M,. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess 1998; 71: 349-367. (Pubitemid 29066373)
82. Dagnan D, Chadwick P, Trower P,. Psychometric properties of the Hospital Anxiety and Depression Scale with a population of members of a depression self-help group. Br J Med Psychol 2000; 73: 129-137. (Pubitemid 30157575)
83. Bedford A, Pauw K, Grant E,. The structure of the Hospital Anxiety and Depression Scale (HAD): an appraisal with normal, psychiatric, and medical patient subjects. Pers Individ Dif 1997; 23: 473-478. (Pubitemid 127337777)
84. Soriano J, Salavert L,. The Hospital Anxiety and Depression Scale questionnaire in physical danger and evaluation situations. Counsel Psychol Q 1996; 9: 281-296. (Pubitemid 26371905)
85. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM,. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Med 1997; 27 (2): 363-370. (Pubitemid 27139969)
86. Hammerlid E, Ahlner-Elmqvist M, Bjordal K, et al,. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999; 80: 766-774. (Pubitemid 29209839)
87. Costantini M, Musso M, Viterbori P, et al,. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 1999; 7: 121-127. (Pubitemid 29187558)
88. Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M,. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993; 2 (3): 193-203. (Pubitemid 23203443)